SCHEMBL3663733

SCHEMBL3663733

O=C(NC1CCN(C(I)c2ccccc2)CC1)c1cc2cc(OC3CCN(c4ccc(C(F)(F)F)cc4)CC3)ccc2o1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 1/20 0.43
EPHX2 P34913 2/20 0.40
HRH3 Q9Y5N1 3/20 0.39
SCN9A Q15858 2/20 0.38
SCN1A P35498 1/20 0.38
SCN5A Q14524 1/20 0.38
MCHR1 Q99705 3/20 0.38
KCNH2 Q12809 2/20 0.38
CYP3A4 P08684 1/20 0.38
SLC6A5 Q9Y345 1/20 0.38
DRD4 P21917 1/20 0.38
HTR1A P08908 1/20 0.38
DRD2 P14416 1/20 0.38
HTR2A P28223 1/20 0.38
RAB9A P51151 1/20 0.37
ATF4 P18848 1/20 0.37
TEAD1 P28347 1/20 0.37
FFAR1 O14842 1/20 0.37
ACHE P22303 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3665644 0.93 CHRM4 (0.43) EPHX2HRH3MCHR1HTR1ADRD2
SCHEMBL3663685 0.87 HRH3 (0.52) EPHX2HRH3SCN9ASCN1ASCN5A
SCHEMBL3668600 0.86 DRD4 (0.52) MCHR1KCNH2SLC6A5DRD4FFAR1
SCHEMBL649755 0.86 SLC6A5 (0.54) SLC6A4MCHR1KCNH2SLC6A5DRD4
SCHEMBL4431231 0.84 SCN9A (0.46) EPHX2HRH3SCN9ASCN1ASCN5A
SCHEMBL648264 0.84 SLC6A4 (0.45) SLC6A4SCN9AMCHR1SLC6A5HTR1A
SCHEMBL4427569 0.84 HRH3 (0.51) EPHX2HRH3SCN9ASCN1ASCN5A
SCHEMBL3659838 0.83 SLC6A4 (0.43) SLC6A4EPHX2SCN9AMCHR1KCNH2
SCHEMBL648322 0.83 DRD4 (0.52) SLC6A4MCHR1KCNH2SLC6A5DRD4
Hydrochloric Acid SCHEMBL647344 0.83 SLC6A4 (0.44) SLC6A4SCN9AMCHR1SLC6A5HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231600-A1 CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS Rigel Pharmaceuticals, Inc. (US) 2010-09-29 EP claimed
WO-2009065131-A1 CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS RIGEL PHARMACEUTICALS, INC. (US) 2009-05-22 WO claimed